Decreased RARβ expression induces abundant inflammation and cervical precancerous lesions

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Vitamin A receptors, including Retinoid Acid Receptor β (RARβ), are known to protect against cancer.
• Epigenetic silencing of RARβ occurs during tumor progression.
• Cervical cancer (CC) is linked to high-risk human papillomavirus (HR-HPV), but host factors influence disease outcome.

Purpose of the Study:

• To investigate the impact of reduced RARβ expression on cervical premalignant lesion development.
• To understand the role of RARβ in cervical carcinogenesis and HR-HPV infection susceptibility.

Main Methods:

• Utilized conditional mice (RARβ(L-/L-)) with abated RARβ expression.
• Analyzed cervical tissue for histological changes, cell proliferation, differentiation, apoptosis, and protein levels.

Main Results:

• RARβ(L-/L-) mice developed spontaneous squamous metaplasia and inflammatory infiltrate in the cervix.
• Observed enhanced mitotic activity, reduced cell differentiation, decreased apoptosis, and lower p16(INK4a) protein levels.
• These changes resemble moderate dysplasia, a hallmark of cervical precancer.

Conclusions:

• Low RARβ expression may drive cervical dysplasia by downregulating p16(INK4a), promoting chronic inflammation, and reducing apoptosis.
• Abated RARβ expression appears to increase vulnerability to HR-HPV and early-stage cervical carcinogenesis.